����ӰԺ

• Drug testing plays a critical role in patient care, forensic investigations, and workplace safety 
• While testing needs widely vary, reliable and high-quality results support confident decision-making 
• The intuitive Atellica DT 250 Analyzer offers fast, comprehensive drug testing 

A new benchtop analyzer from Siemens Healthineers is making quality drug testing easier to perform, to help prevent inaccurate results no matter where, or by whom, testing is conducted. The Atellica DT 250 Analyzer helps identify substance use, monitor therapeutic and immunosuppressant drugs, and perform serum toxicology testing.¹ It also offers automated specimen validity testing to detect substitution, adulteration, and dilution of urine samples, to flag suspicious samples early and prevent the bottleneck that delays results when creative methods to cover up recreational or illegal drug use are attempted. The broad drug testing capabilities of the Atellica DT 250 Analyzer make it an ideal instrument for use in clinical settings such as physician offices and hospitals, and in non-clinical settings where operator skill may vary by user, such as treatment and pain management centers, forensic laboratories, military, and employment testing. 

While drug testing is commonly known for determining whether harmful substances are present in one’s system or being misused, it also provides important information that helps doctors care for their patients. Determining potential drug interactions, ensuring prescribed medications are metabolized within therapeutic ranges, and optimizing medication dosing are all important drug testing needs that depend upon reliable results. 

“Quality should be non-negotiable when the stakes for drug testing are so high,” said Duncan Porter, head of Syva, Immulite, and Plasma Proteins for Siemens Healthineers. “We engineered an easy-to-use, reliable, and highly productive instrument that offers flexible testing capabilities to match individual drug testing needs and reduce operational costs that are top of program directors’ minds.” 

The Atellica DT 250 Analyzer, which is now widely available globally, streamlines drug testing capabilities previously limited to larger, floor-standing models onto one benchtop analyzer. It can process 225 test results per hour, a 69% increase in productivity over the legacy Viva-ProE drug testing system from Siemens Healthineers, with first results provided in as soon as eight minutes.² The instrument relies on widely validated reagents, the trusted Syva EMIT technology, and offers an immunoassay menu of more than 65 assays for use with urine, serum, and plasma (blood) samples. It also offers 10 open channels for customizable, user-defined testing for added flexibility.

Further information on the Atellica DT 250 Drug Testing Analyzer can be found here.